Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12158259 | 0.89 | TSHR (0.49) | KMT2ACA12CA7CA9CA14 | |
| SCHEMBL7980726 | 0.88 | KMT2A (0.55) | KMT2AALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL11062361 | 0.87 | CA12 (0.47) | KMT2ACA12CA7CA9CA14 | |
| SCHEMBL7751977 | 0.85 | KMT2A (0.51) | KMT2AALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL19586242 | 0.84 | HPGD (0.49) | KMT2AALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL21465795 | 0.84 | ALDH1A1 (0.49) | KMT2AALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL2288515 | 0.83 | KMT2A (0.56) | KMT2AESR1ESR2MEN1GAA | |
| SCHEMBL1545921 | 0.83 | KMT2A (0.56) | KMT2AALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL6390962 | 0.83 | KMT2A (0.56) | KMT2AALDH1A1ESR1ESR2MEN1 | |
| SCHEMBL28970084 | 0.82 | MTNR1A (0.53) | KMT2ACA12CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3181546-B1 | METHOD OF DOUBLE CARBONYLATION OF ALLYLIC ALCOHOLS IN ORDER TO FORM CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2018-05-02 | — | — | EP | disclosed |
| EP-3181547-B1 | METHOD FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2018-04-04 | — | — | EP | disclosed |
| US-9850194-B2 | Process for double carbonylation of allyl alcohols to corresponding diesters | EVONIK DEGUSSA GMBH (DE) | 2017-12-26 | — | — | US | disclosed |
| US-9850194-B2 | Process for double carbonylation of allyl alcohols to corresponding diesters | EVONIK DEGUSSA GMBH (DE) | 2017-12-26 | — | — | US | disclosed |
| US-9815766-B2 | Process for double carbonylation of allyl ethers to corresponding diesters | EVONIK DEGUSSA GMBH (DE) | 2017-11-14 | — | — | US | disclosed |
| US-20170174610-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ALCOHOLS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170174610-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ALCOHOLS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| EP-3181546-A1 | METHOD OF DOUBLE CARBONYLATION OF ALLYLIC ALCOHOLS IN ORDER TO FORM CORRESPONDING DIESTERS | Evonik Degussa GmbH (DE) | 2017-06-21 | — | — | EP | disclosed |
| EP-3181547-A1 | METHOD FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | Evonik Degussa GmbH (DE) | 2017-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | CBR3, CBR1, EPOR | KMT2A 1663/4885CA12 428/4885CA7 1141/4885 |
| US-20170174610-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ALCOHOLS TO CORRESPONDING DIESTERS | CBR3, ADH1C, CBR1 | KMT2A 2008/4885CA12 430/4885CA7 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.